Recent Updates
Recently added Catalysts
TFX Positive Sentiment

Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma

Wednesday, July 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Teleflex Incorporated has received FDA approval for its EZPLAZ™ Freeze Dried Plasma, designed for transfusion in adults experiencing bleeding-related conditions. This approval signifies an important advancement in medical technology, particularly for patients requiring plasma coagulation factors. The product aims to enhance treatment options for uncontrolled bleeding.
Price reaction · baseline $134.65 (2026-07-29 close) · hit after-hours · clean, no other TFX news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • FDA approval for EZPLAZ™ Freeze Dried Plasma is a significant milestone.
  • The product addresses critical needs in transfusion for bleeding-related conditions.
  • Teleflex strengthens its portfolio with innovative medical technology.

Full Press Release Details

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has received Biologics License Application (BLA) approval for EZPLAZ™ Freeze Dried Plasma (FDP) from the U.S. Food and Drug Administration (FDA). EZPLAZ™ FDP is approved for transfusion in adults with bleeding-related conditions requiring replacement of plasma coagulation factors, including uncontrolled bleeding (hemorrhage), when plasma is required and other pla

Frequently Asked Questions

What is EZPLAZ™ Freeze Dried Plasma?

EZPLAZ™ Freeze Dried Plasma is a product approved for transfusion in adults with bleeding-related conditions.

Who approved EZPLAZ™ Freeze Dried Plasma?

The U.S. Food and Drug Administration (FDA) approved EZPLAZ™ Freeze Dried Plasma.

What conditions does EZPLAZ™ address?

EZPLAZ™ is designed for patients requiring replacement of plasma coagulation factors due to uncontrolled bleeding.

What company developed EZPLAZ™?

EZPLAZ™ was developed by Teleflex Incorporated, a global provider of medical technologies.

ShareAdd on Google
Tags: TFX Teleflex FDA Approval EZPLAZ Freeze Dried Plasma biologics
Last updated: Jul 29, 2026

Biotech snapshot

Cash runway
$327M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Arterial SealingPhase 3
Hemostasis of Arterial Punctures →